Kyle, Theodore K.Stanford, Fatima2020-05-272016Kyle, Theodore K., and Fatima Cody Stanford. 2016. Low Utilization of Obesity Medications: What Are the Implications for Clinical Care? Obesity 24, no. 9 (August 29): 1832–1832.1930-7381http://nrs.harvard.edu/urn-3:HUL.InstRepos:42668778In a new analysis of dispensed prescriptions for obesity medications, Thomas et al. (1) quantify the extent of a problem that until now has only been described qualitatively. Prescribing of obesity medications, and especially obesity medications approved by the FDA in the past 4 years, is at a low level that appears to be incongruous with the extent of the unmet need for clinical care in obesity.en-USLow Utilization of Obesity Medications: What are the Implications for Clinical Care?Journal Article2017-12-0720162020-05-2710.1002/oby.21566